Evidence map›Paper›PMID 35784456›Full record

ArticleFrontiers in cell and developmental biology2022

Mapping of the sGC Stimulator BAY 41-2272 Binding Site on H-NOX Domain and Its Regulation by the Redox State of the Heme.

Garyfallia I Makrynitsa, Aikaterini I Argyriou, Aikaterini A Zompra, Konstantinos Salagiannis, Vassiliki Vazoura, Andreas Papapetropoulos, Stavros Topouzis, Georgios A Spyroulias

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Garyfallia I MakrynitsaDepartment of Pharmacy, University of Patras, Patras, Greece.
Aikaterini I ArgyriouDepartment of Pharmacy, University of Patras, Patras, Greece.
Aikaterini A ZompraDepartment of Pharmacy, University of Patras, Patras, Greece.
Konstantinos SalagiannisLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Greece.
Vassiliki VazouraLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Greece.
Andreas PapapetropoulosLaboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Stavros TopouzisLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Greece.
Georgios A SpyrouliasDepartment of Pharmacy, University of Patras, Patras, Greece.
University of Patras · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soluble guanylate cyclase (sGC) is the main receptor of nitric oxide (NO) and by converting GTP to cGMP regulates numerous biological processes. The

Indexed as

BAY 41-2272cGMP (cyclic GMP)H-NOX domainnitric-oxide (NO)NMR spectroscopysoluble guanylate cyclase (sGC)

Identifiers

PMID35784456
PMCPMC9247194
OpenAlexW4283029765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.